Virtu Financial’s Microbot Medical MBOT Stock Holding History

Virtu Financial’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$96K	Sell	40,042 -18,632	-32%	-$41.6K	﹤0.01%	1199
2025 Q4	$117K	Buy	+58,674	New	+$139K	﹤0.01%	1170
2025 Q2	–	Sell	-27,655	Closed	-$42K	–	1805
2025 Q1	$42K	Buy	+27,655	New	+$48.9K	﹤0.01%	1030
2024 Q3	–	Sell	-13,379	Closed	-$14K	–	1670
2024 Q2	$14K	Buy	+13,379	New	+$13.8K	﹤0.01%	1081
2024 Q1	–	Sell	-42,046	Closed	-$69K	–	1798
2023 Q4	$69K	Buy	42,046 +18,138	+76%	+$24.2K	0.01%	1116
2023 Q3	$33K	Buy	+23,908	New	+$51.9K	﹤0.01%	947
2022 Q1	–	Sell	-12,622	Closed	-$95K	–	1799
2021 Q4	$95K	Buy	+12,622	New	+$81.3K	0.01%	1150
2019 Q4	$606K	Buy	+59,598	New	+$349K	0.06%	348
2018 Q3	–	Sell	-5,139	Closed	-$57K	–	1929
2018 Q2	$57K	Buy	+5,139	New	+$62.6K	﹤0.01%	1736

Other funds holding MBOT

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CBU

CIBC Bancorp USA Chicago, Illinois $74.4B AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Virtu Financial's MBOT Position: Q1 2026 in Review

Virtu Financial reduced its Microbot Medical (MBOT) stake by 32% in Q1 2026, selling an estimated $41.6K and leaving 40,042 shares worth $96K. The position accounts for ﹤0.01% of the portfolio, ranked #1199.

Virtu Financial first reported a position in MBOT in Q2 2018 and has held it in 9 quarters since. The position peaked at $606K in Q4 2019. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

Virtu Financial held 40,042 shares of Microbot Medical worth $96K as of Q1 2026.
Virtu Financial sold 18,632 Microbot Medical shares in Q1 2026, an estimated $41.6K.
Microbot Medical made up ﹤0.01% of Virtu Financial's portfolio in Q1 2026, its #1199 holding.
Virtu Financial first reported a position in Microbot Medical in Q2 2018 and has held it in 9 quarters since.
Virtu Financial's Microbot Medical position peaked at $606K in Q4 2019.
79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.